RealTalk MS
RealTalk MS
Navigating multiple sclerosis is easier when you understand the science behind it. Join host Jon Strum each week as he translates complex MS research, treatment breakthroughs, and healthcare news into clear, accessible language. Whether you’re living with MS, caring for a loved one, or looking for answers, RealTalk MS connects you with top neuroscientists, advocates, and the information and insights that matter most to your MS journey.
Choose your favorite podcast player
June 1, 2026

Episode 457: From the 2026 CMSC Annual Meeting with Dr. Kathy Zackowski, Dr. Valerie Block, and Dr. Riley Bove

Episode 457: From the 2026 CMSC Annual Meeting with Dr. Kathy Zackowski, Dr. Valerie Block, and Dr. Riley Bove
RealTalk MS
Episode 457: From the 2026 CMSC Annual Meeting with Dr. Kathy Zackowski, Dr. Valerie Block, and Dr. Riley Bove

Last week, the Consortium of Multiple Sclerosis Centers, best known as CMSC, hosted its annual meeting in Charlotte, North Carolina, where we had a chance to talk with some of the world's top MS experts. We'll be sharing those conversations over the next few episodes of the podcast. Welcome to Part One of our coverage of CMSC 2026!

CMSC logo

In what has become an annual tradition at this conference, Dr. Kathy Zackowski, the National MS Society's Associate Vice-President of Research, joins me to share her impressions of the sessions and presentations that stood out to her.

I also caught up with Dr. Valerie Block and Dr. Riley Bove on the first day of the CMSC annual meeting, and we discussed how wearable devices and digital tools are finding their way into MS care and how they can improve the quality of care for people living with MS.

We have a lot to talk about! Are you ready for RealTalk MS??!


This Week: We're reporting from CMSC :22

Dr. Kathy Zackowski shares the CMSC presentations that caught her eye 1:04

Dr. Valerie Block and Dr. Riley Bove discuss how wearable devices and digital tools are reshaping MS care 14:29

Share this episode 28:20

Next week 28:39


SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/457

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!


LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com

JOIN: The RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

REVIEW: Give RealTalk MS a rating and review
http://www.realtalkms.com/review


Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 457
Guests: Dr. Kathy Zackowski, Dr. Valerie Block, Dr. Riley Bove

WEBVTT

00:00:02.920 --> 00:00:05.940
I'm Jon Strum, and this is Real Talk MS.

00:00:18.120 --> 00:00:21.320
It's June 2nd, and we have a lot to talk about.

00:00:21.840 --> 00:00:26.360
Last week, the Consortium of Multiple Sclerosis Centers, better known by the

00:00:26.360 --> 00:00:31.020
acronym CMSC, hosted its annual meeting in Charlotte, North Carolina,

00:00:31.280 --> 00:00:35.160
where we had a chance to talk with some of the top MS experts in the world.

00:00:35.480 --> 00:00:39.640
We'll be sharing those conversations over the next few episodes of the podcast.

00:00:40.000 --> 00:00:44.080
And in what has become an annual tradition at this conference, Dr.

00:00:44.240 --> 00:00:48.940
Kathy Zukowski, the National MS Society's Associate Vice President of Research,

00:00:49.140 --> 00:00:55.380
joined me to share her impressions of the sessions and presentations that especially stood out to her.

00:00:55.580 --> 00:00:59.500
In a moment, we'll hear my conversation with Dr. Kathy Zackowski.

00:01:04.220 --> 00:01:10.300
Each year, one of my favorite parts of the Consortium of MS Center's annual meeting is when Dr.

00:01:10.440 --> 00:01:14.560
Kathy Zukowski, the Associate Vice President of Research at the National MS

00:01:14.560 --> 00:01:19.580
Society, drops by to share her perspective on some of the sessions at the conference

00:01:19.580 --> 00:01:21.840
that she found particularly interesting.

00:01:22.220 --> 00:01:25.320
As you can see, she takes a lot of very careful notes.

00:01:26.140 --> 00:01:28.300
Welcome back to the podcast, Dr. Zackowski.

00:01:28.500 --> 00:01:30.420
Thank you for having me. It's a pleasure to be back.

00:01:30.660 --> 00:01:34.020
It would not be the same conference if I didn't get to talk to you.

00:01:34.140 --> 00:01:36.000
It's truly my favorite part.

00:01:36.460 --> 00:01:40.480
You know, there's an awful lot being presented this year,more sessions

00:01:40.480 --> 00:01:44.380
and ever before. Which presentations have you found to be noteworthy?

00:01:45.270 --> 00:01:50.850
Yeah, so it's only the beginning, right? Today is day one. So already we've had Dr.

00:01:50.990 --> 00:01:54.850
Anthony Feinstein give a really great keynote speech.

00:01:55.130 --> 00:01:58.730
And what I really appreciated about his talk, Dr.

00:01:58.910 --> 00:02:04.450
Feinstein is a psychiatrist from Canada who has been in the field of MS for a very long time.

00:02:04.630 --> 00:02:12.950
But he really highlighted historically how we've learned about depression and cognition over time.

00:02:13.150 --> 00:02:17.670
And I thought it was really great how he linked the importance of imaging to

00:02:17.670 --> 00:02:22.730
our understanding of especially depression and how we've learned to not view

00:02:22.730 --> 00:02:27.870
depression as a reaction to how people respond to the disease,

00:02:27.870 --> 00:02:30.410
but actually as it's integrated with the disease.

00:02:30.610 --> 00:02:35.210
And so that really has changed how we treat depression because we know it has

00:02:35.210 --> 00:02:36.870
a biologic relevance to MS.

00:02:37.150 --> 00:02:42.110
And I know that's not new news, but it was really nice to hear how we came to

00:02:42.110 --> 00:02:47.770
that decision and the studies that were required to come to that understanding.

00:02:48.230 --> 00:02:52.370
And another thing, I guess, with his talk was understanding the importance of

00:02:52.370 --> 00:02:59.930
cognitive reserve and how it's not just you need to work hard and play hard, is how he put it.

00:03:00.050 --> 00:03:03.530
And my understanding of that was you We need to work your brain,

00:03:03.630 --> 00:03:06.330
so we need to be doing focused activities with how we think,

00:03:06.510 --> 00:03:10.610
but then we also need to play, and by that we need to be social and make lots

00:03:10.610 --> 00:03:15.590
of connections, because both of those things help build what's called cognitive reserve.

00:03:15.870 --> 00:03:20.550
And when you have MS, if cognition starts to become a problem,

00:03:20.770 --> 00:03:25.070
the more you've built up your cognitive reserve, the less you will feel some

00:03:25.070 --> 00:03:28.190
of those changes in your overall function.

00:03:28.960 --> 00:03:33.580
You know, one of the things I really appreciate about Dr. Feinstein is when

00:03:33.580 --> 00:03:39.160
you hear a therapist talk about something, very often you come away thinking,

00:03:39.460 --> 00:03:43.920
well, they spend all day talking to their patients and listening to people and

00:03:43.920 --> 00:03:49.000
they have opinions, but it's kind of a soft science until you meet Anthony Feinstein

00:03:49.000 --> 00:03:53.520
because he brings all the evidence and he has it.

00:03:53.520 --> 00:03:59.960
He actually, as we heard,he does functional MRI so he can see what

00:03:59.960 --> 00:04:04.200
part of the brain is being activated and how that relates to MS and other things.

00:04:04.360 --> 00:04:08.100
And, yeah, he's been doing it a long time. And in addition to all his research,

00:04:08.520 --> 00:04:12.140
his practice focuses on people living with MS.

00:04:12.380 --> 00:04:17.080
Yeah, and I think he set a really nice precedent in that he ran a really large

00:04:17.080 --> 00:04:19.440
clinical trial that ended about two years ago.

00:04:19.440 --> 00:04:24.760
And he didn't meet his primary outcome, but he has done enough of secondary

00:04:24.760 --> 00:04:28.540
analyses to pull out of that. What are the important elements of that trial?

00:04:28.780 --> 00:04:32.840
I think that's a really important lesson for many scientists to take home, too.

00:04:33.800 --> 00:04:38.400
And it's great to have that lesson in analysis come from a therapist, right?

00:04:38.840 --> 00:04:42.320
Yeah, definitely. Yeah, you're right. He's very good at translating all of the

00:04:42.320 --> 00:04:44.320
science into why do I care?

00:04:45.200 --> 00:04:47.460
If I have MS, why do I care about all this?

00:04:47.460 --> 00:04:51.240
Right. And he can tell you exactly why you should. Exactly. Right.

00:04:51.640 --> 00:04:52.780
What else happened today?

00:04:52.780 --> 00:04:57.000
So, well, I'm going to tell you about yesterday. So I was in an all-day meeting.

00:04:57.260 --> 00:05:02.420
It was called the Fellowship Forum, and it was about 100 fellows.

00:05:02.420 --> 00:05:09.120
So these are physicians and other clinician providers who are still in training,

00:05:09.120 --> 00:05:14.200
but at the very tail end of their training, before they start out on their career in MS.

00:05:14.200 --> 00:05:17.140
And they're invited for a day

00:05:17.140 --> 00:05:22.660
where I took part in a couple of panels where about 10 of us who are...

00:05:23.770 --> 00:05:29.390
Scientists or clinicians in MS basically talked about how we got to this part of our career.

00:05:29.550 --> 00:05:32.790
Like, how did we end up studying MS? How did we end up treating MS?

00:05:32.990 --> 00:05:35.770
Why do we want careers in this area?

00:05:36.330 --> 00:05:40.550
And I thought it was just really important to be talking to that younger generation.

00:05:40.730 --> 00:05:43.850
So the panel was like, we're here now doing it.

00:05:43.970 --> 00:05:48.770
And then everyone in the audience, 100 fellows, they're the future of what we're expecting.

00:05:48.990 --> 00:05:53.070
And there is a really bright future for this. I mean, And the onset of AI,

00:05:53.370 --> 00:05:57.650
the use of more technology, all of those things are just at the very beginning

00:05:57.650 --> 00:06:03.910
stages. And I think we need these young scientists and strong minds to move the field forward.

00:06:04.630 --> 00:06:09.590
Absolutely. Having that next generation of MS experts is really, really important.

00:06:09.590 --> 00:06:14.090
And I don't know if everybody watching us knows how the National MS Society

00:06:14.090 --> 00:06:21.270
for years has had a formal program to recruit and support MS fellows so that

00:06:21.270 --> 00:06:23.270
next generation of experts will be there.

00:06:23.470 --> 00:06:27.890
Yeah, I mean, we even started a program for undergraduates. So it's a summer

00:06:27.890 --> 00:06:33.210
program, and it's essentially for college students who might be interested in

00:06:33.210 --> 00:06:37.970
science but have never had an opportunity to really participate in a research laboratory.

00:06:37.970 --> 00:06:45.150
So the society has picked out 14 of these individuals, and we've also paired

00:06:45.150 --> 00:06:48.450
them with established scientists in the MS area.

00:06:48.450 --> 00:06:53.810
And we pay the scientist to bring these people on, and then we pay the student

00:06:53.810 --> 00:07:00.090
to be able to move to where that scientist is, spend 10 weeks in their laboratory, and learn about MS.

00:07:00.310 --> 00:07:04.690
And the hope is that before you even made a decision what kind of work you're

00:07:04.690 --> 00:07:07.430
going to do, we want to get you excited about MS research.

00:07:07.970 --> 00:07:12.670
It just got me excited. Sorry I missed that opportunity a few decades ago.

00:07:13.330 --> 00:07:16.110
Yeah, I think it's really fun. This is only our second year,

00:07:16.150 --> 00:07:18.390
but the first year reviews were really good.

00:07:18.570 --> 00:07:22.230
Both the mentors and the students loved it. So it seems like it's going well.

00:07:22.430 --> 00:07:23.090
Oh, that's awesome.

00:07:23.690 --> 00:07:26.350
Anything else occur to you in the last day and a half?

00:07:26.810 --> 00:07:29.490
Well, one thing I want to talk about that hasn't happened yet,

00:07:29.490 --> 00:07:33.850
but will happen tomorrow morning, but I think is really interesting is there's

00:07:33.850 --> 00:07:38.170
a small symposium called the International Symposium on Gait and Balance in MS.

00:07:38.370 --> 00:07:44.670
And it's a day-long program that happens every year, and it's really designed

00:07:44.670 --> 00:07:50.910
to help give scientists a place to network, really focused on gait and balance

00:07:50.910 --> 00:07:51.970
and multiple sclerosis.

00:07:51.970 --> 00:07:57.190
And this year, we are collaborating with the consortium of MS centers.

00:07:57.210 --> 00:08:02.450
And so we're having a session, a morning session tomorrow that is focused on

00:08:02.450 --> 00:08:04.970
wheelchair falls and safety.

00:08:05.170 --> 00:08:09.570
And so we brought three different scientists in to talk about different aspects,

00:08:09.570 --> 00:08:15.050
because you might not even think that someone in a wheelchair would be at risk of falling.

00:08:15.050 --> 00:08:19.630
But it turns out that there's studies and there's evidence that this is a problem

00:08:19.630 --> 00:08:21.350
and that we need to better understand

00:08:21.350 --> 00:08:26.310
how to keep people who have to be in wheelchairs safe and mobile,

00:08:26.310 --> 00:08:32.230
but teach the providers also, like, how best to help those patients.

00:08:32.910 --> 00:08:37.610
You know, one of the issues I should explain to our viewers is,

00:08:37.790 --> 00:08:41.850
when you come to a conference like this, you can't be everywhere at once.

00:08:42.330 --> 00:08:47.010
You need to make hard choices sometimes, and there are some conflicts that won't

00:08:47.010 --> 00:08:48.590
go away, that you can't get out of.

00:08:49.070 --> 00:08:52.010
That's a session I'm going to have to miss. So…

00:08:52.420 --> 00:08:57.520
I contacted one of those experts, one of those scientists who's going to be presenting tomorrow.

00:08:58.160 --> 00:09:02.400
And my audience will be happy to know that Dr. Laura Rice will be joining us

00:09:02.400 --> 00:09:03.780
in just a couple of weeks.

00:09:03.960 --> 00:09:09.080
She has already given me a preview on what she's talking about tomorrow.

00:09:09.440 --> 00:09:13.500
So we still get to share that, even though I don't get to sit in on the session.

00:09:13.660 --> 00:09:16.820
That's great. I'm glad to hear that you pulled her out. I think she'll be really

00:09:16.820 --> 00:09:22.280
great. And, yeah, it's just sort of a unique aspect of what people have to get

00:09:22.280 --> 00:09:23.860
through if they're living in a wheelchair.

00:09:24.460 --> 00:09:28.680
Very true. Absolutely. And you're right. People think, oh, you're in a chair.

00:09:29.000 --> 00:09:33.420
You can't fall. Well, not only can you, but when you fall and there's a chair

00:09:33.420 --> 00:09:35.580
involved, you can get seriously injured.

00:09:35.800 --> 00:09:40.300
Right. Right. So we need to understand what do we know now? What are the gaps?

00:09:40.640 --> 00:09:45.880
And how do we teach providers and people with MS the important things to be careful about?

00:09:45.880 --> 00:09:51.920
Especially when people in the rehabilitation field are reminding us how important

00:09:51.920 --> 00:09:54.820
exercise is at every level of ability.

00:09:55.000 --> 00:09:57.800
And that includes people who may be wheelchair bound.

00:09:58.020 --> 00:10:03.940
They need to clearly understand how to exercise safely so they get the benefit

00:10:03.940 --> 00:10:06.080
without putting themselves at risk, right? Right.

00:10:06.220 --> 00:10:10.820
And one of the speakers, Stephanie Silvera, is going to be talking about a specific

00:10:10.820 --> 00:10:15.180
study that she's doing, which is looking at exercise for people who are in wheelchairs.

00:10:15.460 --> 00:10:20.180
So, right, it's all, you know, that's the beauty of this meeting is really being

00:10:20.180 --> 00:10:26.240
able to invite the comprehensive care team here and to share, you know,

00:10:26.320 --> 00:10:31.000
results from studies, but also to network and to build collaborations so that

00:10:31.000 --> 00:10:33.180
we can solve some of these things more quickly.

00:10:33.880 --> 00:10:40.140
I know your professional background is in rehabilitation, and you are an associate

00:10:40.140 --> 00:10:44.000
vice president of research, which involves more than rehabilitation.

00:10:44.720 --> 00:10:49.320
Have you noticed an increase in the science being presented at CMSC?

00:10:49.680 --> 00:10:55.820
I have. This year has been astounding, actually. Very, very strong changes in

00:10:55.820 --> 00:11:00.640
programming that have really been exciting for me to watch. So I have to make choices.

00:11:00.960 --> 00:11:05.000
Like, so you can't, there are, at this particular meeting, there are multiple

00:11:05.000 --> 00:11:07.900
sessions at the same time. So you have to choose which one to go to.

00:11:08.040 --> 00:11:11.860
And I'm so glad that some of the sessions are being recorded because that's

00:11:11.860 --> 00:11:15.140
what I'll have to do because you can't be in more than one place at one time.

00:11:15.300 --> 00:11:18.860
But I've been, yeah, very excited about these changes. I hope that that continues

00:11:18.860 --> 00:11:24.520
because I also think it's important for physicians to be aware of some of these

00:11:24.520 --> 00:11:28.060
issues that they might not see day to day in their clinic.

00:11:28.060 --> 00:11:32.300
But the other rehabilitation providers really have to grapple with.

00:11:32.420 --> 00:11:35.600
And it's important for the rehabilitation professionals to interact with the

00:11:35.600 --> 00:11:37.420
physicians and understand where they're coming from.

00:11:37.560 --> 00:11:40.180
So this conference allows all of that to happen.

00:11:40.340 --> 00:11:46.140
And at the same time, I think that there is a greater emphasis on bringing rehabilitation

00:11:47.680 --> 00:11:55.200
research more into line with the steps, focus, and analysis that's applied to pure science research.

00:11:55.200 --> 00:12:01.980
Some of that hard analytical approach, I think, being applied to studies in

00:12:01.980 --> 00:12:06.380
rehabilitation makes what we were talking about with Dr. Feinstein before.

00:12:06.660 --> 00:12:11.320
All of a sudden, you have evidence that makes the argument for you.

00:12:11.320 --> 00:12:15.460
Right, right. Because basic biomedical research, you can often control variables

00:12:15.460 --> 00:12:21.180
in a very different way than you do when you're working on a behavioral choice

00:12:21.180 --> 00:12:22.720
or a rehabilitation approach.

00:12:22.840 --> 00:12:28.380
And I think some of those issues need to be, everyone needs to be aware of so

00:12:28.380 --> 00:12:34.020
that we can still build rigorous scientific trials around these behavior interventions.

00:12:35.140 --> 00:12:38.440
Good point. As you were saying that, I was thinking such a difference between

00:12:38.440 --> 00:12:42.300
working with a molecule and working with a whole person. Right, exactly.

00:12:42.580 --> 00:12:46.340
And, you know, and the reality is lots of research is done in animal models,

00:12:46.460 --> 00:12:48.960
which is so needed because you can control those variables.

00:12:49.160 --> 00:12:51.400
But we have to be able to translate that to people.

00:12:51.700 --> 00:12:56.180
And so having, you know, scientists that are trained in human behavior,

00:12:56.420 --> 00:13:00.280
I think that's going to be really important for making that big leap from an

00:13:00.280 --> 00:13:02.600
animal model to a translation to people.

00:13:02.920 --> 00:13:08.600
We're seeing great science this year. We're seeing cutting-edge rehabilitation being presented.

00:13:08.840 --> 00:13:14.660
I think this year is one of the best lineups in terms of content that I've seen in a very long time.

00:13:15.020 --> 00:13:18.780
Yeah, yeah, I agree. Even the Whitaker, so there's a Whitaker research track,

00:13:18.820 --> 00:13:23.520
and there's a couple of people in there that are not basic biomedical researchers.

00:13:23.800 --> 00:13:28.060
And so that track is really designed for kind of the up-and-coming young scientists.

00:13:28.060 --> 00:13:33.360
So it was great to see there's one person looking at aging and MS and really

00:13:33.360 --> 00:13:39.300
trying to not just understand aging using imaging, but using imaging and then

00:13:39.300 --> 00:13:41.100
relating it to clinical factors.

00:13:41.420 --> 00:13:46.640
And so I think that's an example of how this conference offers that opportunity

00:13:46.640 --> 00:13:48.640
and seems to be growing in that direction.

00:13:49.020 --> 00:13:53.520
Dr. Kathy Zukowski, every year this is the conversation I look forward to the

00:13:53.520 --> 00:13:57.160
most. I want to thank you so much for giving us a little bit of your time on

00:13:57.160 --> 00:13:58.860
what I know is an incredibly busy day.

00:13:59.420 --> 00:14:02.160
Well, thank you for giving me a platform to share my thoughts.

00:14:02.160 --> 00:14:03.260
I really appreciate that.

00:14:04.080 --> 00:14:06.960
I caught up with Dr. Valerie Block and Dr.

00:14:07.060 --> 00:14:11.600
Riley Bove on the first day of the CMSC annual meeting, and we discussed

00:14:11.600 --> 00:14:16.620
how wearable devices and digital tools are finding their way into MS care and

00:14:16.620 --> 00:14:21.200
how those tools can actually improve the quality of care for people living with MS.

00:14:21.200 --> 00:14:24.020
In a moment, we'll hear that conversation.

00:14:29.080 --> 00:14:34.480
Today at CMSC, Drs. Valerie Block and Riley Bove were part of a presentation

00:14:34.480 --> 00:14:39.280
on integrating wearable technology into MS clinical care.

00:14:39.620 --> 00:14:43.980
Dr. Block is a physical therapist and assistant professor of physical therapy

00:14:43.980 --> 00:14:47.840
at the UCSF Weill Institute for Neurosciences, and Dr.

00:14:47.940 --> 00:14:52.600
Beauvais is a practicing neurologist and clinician scientist at the UCSF Weill

00:14:52.600 --> 00:14:54.220
Institute for Neurosciences.

00:14:54.220 --> 00:14:58.860
You know, despite the massive amounts of money and development in digital tools,

00:14:59.280 --> 00:15:03.840
very few have actually crossed the divide into routine clinical care.

00:15:04.000 --> 00:15:09.140
So I'll ask each of you, what's the primary roadblock preventing a validated

00:15:09.140 --> 00:15:15.300
digital biomarker or wearable tool from becoming a standard part of an outpatient neurology visit?

00:15:15.500 --> 00:15:20.700
Is it an interface problem, a billing issue, a workflow challenge,

00:15:20.700 --> 00:15:22.800
or something else? Dr. Block?

00:15:22.800 --> 00:15:26.040
Well, I think, for one, it's all of the above.

00:15:26.280 --> 00:15:32.380
And for two, it's that MS is so heterogeneous. So you have to find a tool that

00:15:32.380 --> 00:15:39.320
can pick up the differences for all different people with MS and their symptoms and problems,

00:15:39.320 --> 00:15:44.140
and maybe what's going to predict their disability going forward.

00:15:44.660 --> 00:15:46.240
Dr. Bove, same question.

00:15:46.900 --> 00:15:50.160
Also, all of the above. I think we know that

00:15:51.110 --> 00:15:55.390
different people with MS want to use different tools for different reasons.

00:15:55.590 --> 00:16:01.510
And so there's a gap where we need something that can ingest all the different

00:16:01.510 --> 00:16:04.150
tools and give us the same information.

00:16:04.730 --> 00:16:10.310
On the clinician side, we need that information to get all the way through to

00:16:10.310 --> 00:16:14.390
the clinician's medical record, which is where they make the decisions.

00:16:14.530 --> 00:16:19.410
And that is a workflow issue, and it is a billing issue because that has to

00:16:19.410 --> 00:16:22.150
take up some part of the clinical visit.

00:16:23.470 --> 00:16:27.690
Dr. Bove, you've worked on the Bridge Precision Medicine dashboard to bring

00:16:27.690 --> 00:16:29.750
data directly to the point of care.

00:16:30.170 --> 00:16:35.890
Can this kind of a tool effectively display months of continuous step or sleep

00:16:35.890 --> 00:16:38.430
data to a neurologist in a way that's

00:16:38.430 --> 00:16:42.850
interpretable in what tends to be a relatively brief clinical visit.

00:16:43.150 --> 00:16:48.710
That's absolutely our hope. We're in sort of the trials phase of this because you have to show it.

00:16:48.830 --> 00:16:54.150
But from sort of what we've seen so far, clinicians really appreciate being

00:16:54.150 --> 00:16:55.770
able to see trends over time,

00:16:55.970 --> 00:17:00.590
being able to see when a patient's function dips and discussing with the patient

00:17:00.590 --> 00:17:05.930
why that was so, and also measuring whether the interventions that they recommend

00:17:05.930 --> 00:17:09.310
happened and reached the target goal.

00:17:10.880 --> 00:17:16.360
Dr. Block, as a physical therapist and researcher, how does the clinical utility

00:17:16.360 --> 00:17:23.300
of this data differ between a neurology evaluation and a physical therapy or

00:17:23.300 --> 00:17:24.520
rehabilitation setting?

00:17:25.060 --> 00:17:30.320
Well, I think what we're trying to do is change behavior more.

00:17:30.320 --> 00:17:38.200
And so using this information maybe as biofeedback or to have a goal,

00:17:38.400 --> 00:17:45.140
like an attainable goal for them to do, and then we have tools and treatment methods to reach those.

00:17:45.140 --> 00:17:50.820
And I think that having something that's actionable, like what Dr.

00:17:50.880 --> 00:17:54.380
Bovey's built with Bridge, and being able to pull that into the clinic,

00:17:54.500 --> 00:18:00.040
not only so I can see and I can act on that data, but also so the patient can see the data,

00:18:00.220 --> 00:18:06.680
and then that can help motivate them and help give them the feedback that they're actually doing better.

00:18:06.680 --> 00:18:11.020
Because a lot of times I tell them you're doing better from when you first came

00:18:11.020 --> 00:18:14.540
in and they don't believe it because they don't see it because they've been

00:18:14.540 --> 00:18:18.400
incrementally changing and they haven't had that visual feedback.

00:18:19.810 --> 00:18:26.250
You're leading work on the wearables for the bladder study using external ultrasound devices.

00:18:26.910 --> 00:18:31.850
Bladder dysfunction impacts the majority of people with MS, but notoriously

00:18:31.850 --> 00:18:34.910
difficult to accurately track between appointments.

00:18:35.550 --> 00:18:39.510
What have you learned through this study about how real-time bladder monitoring

00:18:39.510 --> 00:18:43.930
changes patient self-management and pelvic floor physical therapy?

00:18:45.030 --> 00:18:49.090
So one of the things that I think both the clinician,

00:18:49.610 --> 00:18:54.910
the sort of urologist and myself and the rest of our team hadn't really realized,

00:18:54.910 --> 00:19:02.150
maybe we knew in the background was the variability and the fluctuation of symptoms for bladder symptoms.

00:19:02.390 --> 00:19:06.390
And so what we measure in the clinic could be completely different from how

00:19:06.390 --> 00:19:08.130
they are during the rest of their day.

00:19:08.310 --> 00:19:12.370
So they're telling us that they're not voiding fully and yet we'll do a post-void

00:19:12.370 --> 00:19:15.970
residual or PVR and they fully void their bladder in the clinic.

00:19:16.130 --> 00:19:17.970
But, you know, I believe the patient.

00:19:18.210 --> 00:19:20.690
It's just that we don't have an objective measure, whereas with this,

00:19:20.810 --> 00:19:22.490
we can see that change throughout.

00:19:23.070 --> 00:19:27.410
You know, there's the potential for using it instead of having an indwelling

00:19:27.410 --> 00:19:32.030
catheter, maybe to have, to know when to use a catheter to void,

00:19:32.230 --> 00:19:36.870
to maybe avoid urinary tract infections or other things like that.

00:19:37.110 --> 00:19:42.190
And then one of the things that we've sort of started to see is patients who

00:19:42.190 --> 00:19:46.350
not just with voiding or post-void residual and retention,

00:19:46.650 --> 00:19:54.290
but also people who were trying to get to have less urgency and frequency and

00:19:54.290 --> 00:19:59.370
seeing how much urine is in their bladder and being able to sort of hold it

00:19:59.370 --> 00:20:00.310
just that little bit more.

00:20:00.410 --> 00:20:04.350
Okay, one more ring up and then you can go to the restroom. And then seeing

00:20:04.350 --> 00:20:09.830
how that increases can really help motivate treatment and the patient as well.

00:20:10.920 --> 00:20:17.000
You know, as Dr. Block was explaining the variations between what happens or

00:20:17.000 --> 00:20:20.180
what's measured in the clinic and what happens in real life,

00:20:20.320 --> 00:20:22.840
it occurs to me, it's not just bladder function.

00:20:23.040 --> 00:20:27.880
I'm thinking about the patient that you might see at 9 a.m.

00:20:28.080 --> 00:20:33.660
And their 25-foot walk, and that same patient, same 25-foot walk at 4 p.m.,

00:20:33.660 --> 00:20:39.460
or someone who is dealing with fatigue at home and doesn't happen to be fatigued

00:20:39.460 --> 00:20:40.620
the day they're in clinic.

00:20:40.920 --> 00:20:45.580
It seems that wearables, digital technology, are really going to be able to

00:20:45.580 --> 00:20:52.220
start showing what it really is that that patient deals with day in, day out.

00:20:52.320 --> 00:20:56.220
Yeah, absolutely. You know, in the stroke world, we talk about the penumbra.

00:20:56.540 --> 00:21:01.180
So you have the stroke and you've had some tissue that has sort of lost oxygen

00:21:01.180 --> 00:21:04.540
and, you know, may be beyond repair.

00:21:04.540 --> 00:21:08.400
And then you have some tissue that may be at risk of losing oxygen,

00:21:08.400 --> 00:21:12.020
but that is still functioning.

00:21:12.320 --> 00:21:17.880
And that's sort of the penumbra around the shadow around the stroke territory.

00:21:18.160 --> 00:21:24.760
And I think in multiple sclerosis, just as you say, the ability to see that,

00:21:24.860 --> 00:21:27.180
huh, the walking is fatigable.

00:21:27.360 --> 00:21:29.160
The bladder is variable.

00:21:29.720 --> 00:21:32.940
They do more early morning than they do late afternoon.

00:21:33.320 --> 00:21:39.740
All of that information tells us what domains, what function is actually at

00:21:39.740 --> 00:21:42.180
risk. What is the penumbra of their function?

00:21:42.320 --> 00:21:44.720
What is at risk of worsening or progression?

00:21:45.000 --> 00:21:49.320
And I think that's a really valuable biological signal that we don't have,

00:21:49.540 --> 00:21:52.100
as you say, when we see a patient for one time point.

00:21:52.100 --> 00:21:55.580
Well, I guess to that point, in addition to wearable sensors,

00:21:55.900 --> 00:22:01.860
your lab has looked at consumer-driven digital inputs like selfie videos from

00:22:01.860 --> 00:22:03.880
patients to measure their physical function.

00:22:04.500 --> 00:22:09.840
How do you see passive wearable data and active digital patient-reported outcomes

00:22:09.840 --> 00:22:14.480
working together to create a composite picture of that patient's true status?

00:22:14.680 --> 00:22:19.660
I think, as you say, they have to work together. Passive means the patient isn't

00:22:19.660 --> 00:22:22.900
doing something. They're not responding to a prompt.

00:22:23.000 --> 00:22:27.100
They're not responding to an action. They're just living their daily life,

00:22:27.120 --> 00:22:28.820
and the wearable is measuring that.

00:22:29.400 --> 00:22:33.540
And that gives us a beautiful portrait, sort of longitudinal,

00:22:34.000 --> 00:22:40.160
but the sort of active prompts that we're using when we ask patients to self-record

00:22:40.160 --> 00:22:45.340
their selfies actually gives us a really nice sort of more spot,

00:22:45.580 --> 00:22:48.140
you know, one moment in time or over several days,

00:22:48.380 --> 00:22:51.680
several moments of time where we really see how they're really functioning in

00:22:51.680 --> 00:22:54.500
their daily world, doing things that matter to them,

00:22:55.040 --> 00:22:58.400
buttoning their shirt, feeding themselves, walking in their home.

00:22:58.400 --> 00:23:01.860
And so I think those do provide really complementary information.

00:23:02.380 --> 00:23:06.820
If you want to follow people over the really long term and get a lot of information,

00:23:07.540 --> 00:23:14.660
passive is going to be much better because you can't ask people to do burdensome things all the time.

00:23:14.920 --> 00:23:20.560
But the, you know, a low burden task that you ask them to do several every few

00:23:20.560 --> 00:23:23.000
months, for instance, is totally feasible.

00:23:24.000 --> 00:23:29.680
You know, today's presentation was largely about taking a lot of the data collection

00:23:29.680 --> 00:23:32.140
we're talking about and putting it into the clinic.

00:23:32.340 --> 00:23:35.780
Now, a major promise of wearables, as Dr.

00:23:35.860 --> 00:23:39.740
Block just pointed out, is their ability to detect changes that a patient might

00:23:39.740 --> 00:23:42.200
not even notice or mention during their visit.

00:23:42.200 --> 00:23:48.940
When a wearable dashboard flags a sudden drop in average daily step count or

00:23:48.940 --> 00:23:54.400
a significant disruption in their sleep pattern, what's the protocol for the clinical team?

00:23:54.620 --> 00:24:01.160
How do you prevent that data from creating alarm fatigue for both the clinician and the patient?

00:24:01.160 --> 00:24:04.980
Yeah, that's a great question, and that is really a workflow question.

00:24:05.500 --> 00:24:12.800
And the ideal situation would be that the clinician and the patient together decide on the alarms.

00:24:13.100 --> 00:24:21.420
So if someone is sort of feeling low-grade, you know, a little sad all the time,

00:24:21.580 --> 00:24:25.100
they don't want their doctor alerted every day, right?

00:24:25.100 --> 00:24:31.180
They want to decide what would constitute something that for them is substantially different.

00:24:31.520 --> 00:24:38.140
And I think being able to select the alarm thresholds and triggers is actually

00:24:38.140 --> 00:24:41.280
really key to reducing alarm fatigue long term.

00:24:41.280 --> 00:24:45.920
And then being able to troubleshoot, hey, you know, we are doing this and we've

00:24:45.920 --> 00:24:49.140
sort of, you know, you've gotten better.

00:24:49.420 --> 00:24:54.880
Now let's change the alarm, right, to more restrictive or more permissive, right?

00:24:55.440 --> 00:24:58.940
Let's kind of evolve as the function and the data evolve.

00:24:59.140 --> 00:25:02.600
I think it's going to be a key component because you're right.

00:25:02.780 --> 00:25:06.100
We can't have alarms all day.

00:25:06.940 --> 00:25:11.900
Dr. Block, patients can feel excited and motivated when they see their own data,

00:25:12.080 --> 00:25:15.100
but over time that engagement can taper off.

00:25:15.680 --> 00:25:19.740
What have you found to be the most effective way to keep patients actively involved

00:25:19.740 --> 00:25:23.300
with their wearable devices once the novelty starts to wear off?

00:25:24.800 --> 00:25:29.480
That's a great question. And I think there's not an easy answer to that.

00:25:29.600 --> 00:25:36.060
But with studies and in clinical care, I think it is person to person interaction.

00:25:36.400 --> 00:25:41.680
I think they need to feel kind of some ownership of it. And as Dr.

00:25:41.760 --> 00:25:45.760
Bovey talked about, like designing a tool that they find interesting,

00:25:45.940 --> 00:25:50.040
that they get something back from, that they can see these changes.

00:25:50.380 --> 00:25:54.300
And then I think interaction with the provider that they're seeing you,

00:25:54.520 --> 00:25:57.700
that they're hearing you, that they're understanding some of the things that

00:25:57.700 --> 00:26:02.100
maybe have been difficult to show or elicit in the clinic,

00:26:02.100 --> 00:26:06.580
that they're able to see that and track that and that they are responding to

00:26:06.580 --> 00:26:09.640
that in a way that, you know, we can hopefully see changes.

00:26:10.670 --> 00:26:18.150
Dr. Bove, consumer digital devices are created for the mass market for most people.

00:26:18.990 --> 00:26:23.550
MS presents with a variety of symptoms, including cognitive fatigue,

00:26:24.230 --> 00:26:27.370
manual dexterity challenges, and visual impairments.

00:26:27.510 --> 00:26:33.130
So how do we apply human-centered design to ensure these tools remain accessible

00:26:33.130 --> 00:26:37.210
to patients who might have the highest degree of disability and the most to

00:26:37.210 --> 00:26:39.810
gain from this kind of remote monitoring? Yeah.

00:26:40.050 --> 00:26:45.510
You can imagine that someone who has disability across several domains would

00:26:45.510 --> 00:26:50.210
end up wearing like 16 different devices, right, that need to be paid for,

00:26:50.510 --> 00:26:52.690
charged, calibrated, interpreted.

00:26:52.710 --> 00:26:56.970
And that would be overload for that person. That's not serving the needs of

00:26:56.970 --> 00:27:02.910
that person. So I think, again, the combination of, you know,

00:27:03.050 --> 00:27:06.170
what is low touch, low burden gives you a good snapshot.

00:27:06.510 --> 00:27:11.370
And then what do you want to monitor? And it can be for the time being, right?

00:27:11.510 --> 00:27:14.530
So maybe for the time being, we want to focus on one domain,

00:27:14.730 --> 00:27:19.570
on, you know, getting the person to move around a bit more. And once we sort

00:27:19.570 --> 00:27:25.030
of achieve that goal, maybe we pull in or switch out a new device, right?

00:27:25.350 --> 00:27:29.670
So it doesn't have to be all at the same time forever. I think you can really

00:27:29.670 --> 00:27:33.750
be a little bit more selective based on what you're prioritizing.

00:27:33.750 --> 00:27:38.090
Because we see, for people who have difficulty in multiple domains,

00:27:38.290 --> 00:27:41.870
if you send them out with your long list of all the things they have to do to

00:27:41.870 --> 00:27:44.410
tackle all their symptoms, it's going to be overwhelming, right?

00:27:44.610 --> 00:27:49.090
And so part of the care plan and part of the shared decision-making is figuring

00:27:49.090 --> 00:27:51.790
out, what do we do first and then what do we do next?

00:27:51.970 --> 00:27:56.230
And so I think, similarly, the devices can follow that decision-making as well.

00:27:56.850 --> 00:28:01.330
Well, Dr. Riley Bove, Dr. Valerie Block, it's not often that I find myself

00:28:01.330 --> 00:28:05.870
surrounded by so much expertise, but I want to thank you both for all you do

00:28:05.870 --> 00:28:10.050
to improve the lives of people living with MS. And thanks so much for talking with me today.

00:28:10.390 --> 00:28:11.410
Thank you, Jon. Thank you, Jon.

00:28:13.040 --> 00:28:17.500
That's going to wrap up this episode of Real Talk MS. Real Talk MS is powered

00:28:17.500 --> 00:28:19.180
by the National MS Society.

00:28:19.460 --> 00:28:23.880
And you can share this episode of the podcast by letting your friends or family

00:28:23.880 --> 00:28:31.120
members know that all they have to do is point their web browser at realtalkms.com slash 457.

00:28:31.600 --> 00:28:35.900
You'll find that link in today's show notes so you can easily copy and paste

00:28:35.900 --> 00:28:38.260
it right into an email or a text.

00:28:39.000 --> 00:28:43.720
Next week, we're continuing our coverage of the Consortium of MS Center's annual

00:28:43.720 --> 00:28:47.140
meeting by sharing my conversation with Dr. Stephen Krieger.

00:28:47.400 --> 00:28:52.680
And if you're someone affected by MS, or if you're an MS researcher or clinician,

00:28:53.080 --> 00:28:56.580
I can promise you that this is a conversation you won't want to miss.

00:28:57.180 --> 00:29:03.780
I'm Jon Strum. Thanks for listening. Stay safe and make healthy choices.